We are live on ! Find out more
AIM

Alerce Investment Management Portfolio holdings

AUM $56.8M
1-Year Est. Return 31.17%
This Fund
S&P 500
This Quarter Est. Return
-28.4%
1 Year Est. Return
+31.17%
3 Year Est. Return
+25.12%
5 Year Est. Return
10 Year Est. Return
AUM
$59M
AUM Growth
-$39.3M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
7
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMWL icon
1
American Well
AMWL
$180M
$26.5M 44.93%
315,039
RNTX
2
Rein Therapeutics
RNTX
$63.1M
$8.51M 14.42%
830,472
WHWK
3
Whitehawk Therapeutics
WHWK
$190M
$6.36M 10.77%
374,785
ANNX icon
4
Annexon
ANNX
$834M
$5.34M 9.04%
1,954,978
ASMB icon
5
Assembly Biosciences
ASMB
$498M
$4.59M 7.77%
185,625
GBT
6
DELISTED
Global Blood Therapeutics, Inc.
GBT
$4.37M 7.41%
126,270
AKBA icon
7
Akebia Therapeutics
AKBA
$354M
$3.34M 5.66%
4,652,561

Similar funds

Alerce Investment Management's Q1 2022 Portfolio in Review

As of Q1 2022, Alerce Investment Management held 7 positions worth $59M, down 40% from $98.3M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q1 2022: portfolio turnover was 0%. Alerce Investment Management opened no new positions and made no exits, leaving the 7-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Alerce Investment Management's ten largest holdings make up 100% of its $59M portfolio in Q1 2022.
  • Alerce Investment Management opened 0 new positions and closed 0 in Q1 2022.
  • Alerce Investment Management's portfolio value fell 40% quarter-over-quarter to $59M.

Based on Alerce Investment Management's 13F filing for Q1 2022, filed 13 May 2022.